About Cadence Neuroscience
Cadence Neuroscience is a private company based in Sammamish, Washington. It has reported $29,029,993 raised in three offerings on Form D since July 2017. Its chief executive is Kent Leyde.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 21, 2023 | Feb 28, 2023 | $26,029,994fully sold | 7 | $3.7M | EquityRule 506(b) | Form D ↗ |
| Sep 9, 2019 | Sep 23, 2019 | $2,999,999of $14.9M target | 1 | $2.9M | EquityRule 506(b) | Form D ↗ |
| Jul 14, 2017 | Jul 31, 2017 | $0target not set | 1 | $0 | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $29,029,993 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Cadence Neuroscience's Form D filed Feb 28, 2023.
JH
John Harris
Director
KC
Kevin Chu
Director
KL
Kent Leyde
CEO and director
GB
Gerry Brunk
Director
WS
Warren Sheffield
Executive officer
Earlier filings also listed Andrew Firlik (director, last listed Sep 2019).